Login / Signup

SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration.

Jakob HartmannThomas BajajJoy OttenClaudia KlengelAnne-Kathrin GellnerEllen JunglasKathrin HafnerElmira A AnderzhanovaFiona TangGalen MissigLindsay RexrodeKatelyn X LiMax L PöhlmannDaniel E HeinzRoy LardenoijeNina DedicKenneth M McCulloughTomasz PróchnickiThomas RhombergSilvia MartinelliAntony PaytonAndrew C RobinsonValentin SteinEicke LatzWilliam A CarlezonMathias V SchmidtChristopher MurgatroydSabina BerrettaTorsten KlengelHarry PantazopoulosKerry James ResslerNils Christian Gassen
Published in: bioRxiv : the preprint server for biology (2023)
High levels of proinflammatory cytokines induce neurotoxicity and catalyze inflammation-driven neurodegeneration, but the specific release mechanisms from microglia remain elusive. We demonstrate that secretory autophagy (SA), a non-lytic modality of autophagy for secretion of vesicular cargo, regulates neuroinflammation-mediated neurodegeneration via SKA2 and FKBP5 signaling. SKA2 inhibits SA-dependent IL-1β release by counteracting FKBP5 function. Hippocampal Ska2 knockdown in mice hyperactivates SA resulting in neuroinflammation, subsequent neurodegeneration and complete hippocampal atrophy within six weeks. The hyperactivation of SA increases IL-1β release, initiating an inflammatory feed-forward vicious cycle including NLRP3-inflammasome activation and Gasdermin D (GSDMD)-mediated neurotoxicity, which ultimately drives neurodegeneration. Results from protein expression and co-immunoprecipitation analyses of postmortem brains demonstrate that SA is hyperactivated in Alzheimer's disease. Overall, our findings suggest that SKA2-regulated, hyperactive SA facilitates neuroinflammation and is linked to Alzheimer's disease, providing new mechanistic insight into the biology of neuroinflammation.
Keyphrases